Extended tip spray applicator for two-component surgical sealant, and methods of use thereof

Information

  • Patent Grant
  • 10952709
  • Patent Number
    10,952,709
  • Date Filed
    Thursday, April 2, 2015
    9 years ago
  • Date Issued
    Tuesday, March 23, 2021
    3 years ago
Abstract
Provided is an extended length, flexible or bendable spray tip assembly for use with a multi-component surgical sealant. The tip assembly is particularly suited for use in surgical procedures having limited access to a surgical field, for example, neurosurgical procedures involving infratentorial, skull base, or transsphenoidal craniotomy, as well as the spine. The tip assembly can be used in combination with a multi-component delivery system or applicator.
Description
BACKGROUND OF THE INVENTION

Approximately 1.2 million craniotomy and 6 million spinal procedures are performed annually worldwide. Of those, approximately half of both types of procedures are performed in the United States. Each of these procedures generally requires watertight closure of the dura mater (dura), the leathery membrane that surrounds and protects the brain and spinal cord within their bony confines.


There exists a major unmet need for a product that consistently applies a hydrogel sealant during multiple applications to confined, hard to reach areas of the cranium and spine, creating a watertight dural closure that prevents cerebrospinal fluid (CSF) leakage. Leakage can occur at suture pinholes, incidental tears or other small gaps in the dura. Serious complication can occur including: extra-dural and subcutaneous collections of CSF, known as pseudomeningoceles, acute and chronic problems of wound healing due to CSF collection, compression of neurological tissues, meningitis, encephalitis, headaches, infection, cognitive changes, additional surgical interventions, prolonged hospitalization, and increased cost. Conventional techniques of preventing CSF leaks are often insufficient because they may not completely stop CSF leaks.


Applicant has developed and markets a two-component hydrogel dural sealant suitable for use as an adjunct to standard methods of dural repair, such as sutures, to provide watertight closure to incised or otherwise compromised dura and as an adhesion barrier to limit post-surgical peridural fibrosis and adhesions. U.S. Pat. No. 8,410,189; U.S. Patent Application Publication No. 2007/0196454; both of which are incorporated herein by reference. The two components are a polyalkyleneimine, such as polyethyleneimine (PEI), and a crosslinking reagent which causes the polyalkyleneimine polymers to polymerize, thereby forming a seal. In certain instances, the crosslinking reagent is a polyethylene glycol (PEG) having reactive terminal groups. Generally, the polyalkyleneimine and crosslinking reagent components are combined shortly before or during their application so that they crosslink in situ in the desired location.


Applicant has also developed and markets a number of applicators suitable for use with the two-component dural sealant. U.S. Pat. Nos. 8,323,262; 8,343,183; 8,262,608; U.S. Patent Application Publication No. 2010/0280547; U.S. Patent Application Publication No. 2013/0338631; all of which are incorporated herein by reference.


SUMMARY OF THE INVENTION

An aspect of the invention is a tip assembly, comprising


a proximal end, comprising a Y fitting, the Y fitting comprising

    • a first proximal end (1);
    • a second proximal end (2);
    • a distal end (3);
    • a first fluid channel (4) extending from the first proximal end to the distal end; and
    • a second fluid channel (5) extending from the second proximal end to the distal end;


a distal end;


a mixing nozzle (12), comprising

    • a proximal end (8), comprising a fluid inlet;
    • a distal end (9), comprising a fluid outlet (13), wherein the distal end of the mixing nozzle corresponds to the distal end of the tip assembly; and
    • a mixing chamber (10) disposed between and in fluid communication with the fluid inlet and the fluid outlet;


a tube extending from the distal end of the Y fitting to the proximal end of the mixing nozzle;


a first cannula (6), disposed within and extending along substantially the entire length of the tube, in fluid communication with the first fluid channel of the Y fitting and the fluid inlet of the mixing nozzle; and


a second cannula (7), disposed within and extending along substantially the entire length of the tube, in fluid communication with the second fluid channel of the Y fitting and the fluid inlet of the mixing nozzle;


wherein the tube, the first cannula, and the second cannula are flexible.


An aspect of the invention is a multi-component delivery system, comprising the tip assembly described herein. In a preferred embodiment, the tip assembly of the invention is substituted for the corresponding tip assembly in the multi-component delivery system disclosed in U.S. Patent Application Publication No. 2013/0338631, the entire content of which is incorporated herein by reference.


An aspect of the invention is a method of using the tip assembly of the invention. The method comprises the steps of:

    • bringing a source of a first component of a two-component hydrogel into fluid communication with the first fluid channel;
    • bringing a source of a second component of a two-component hydrogel into fluid communication with the second fluid channel;
    • causing the first component to traverse the first cannula;
    • causing the second component to traverse the second cannula;
    • causing the first component to mix with the second component within the mixing chamber, thereby forming a pre-hydrogel mixture; and
    • expelling the pre-hydrogel mixture through the fluid outlet of the mixing nozzle, thereby forming a spray of the pre-hydrogel mixture.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 depicts an applicator with a short tip shown at the left.



FIG. 2 depicts top, side, end-on, section, and detail section views of a tip of the invention.



FIG. 3 depicts an exploded view of the tip of FIG. 2.



FIG. 4 depicts an exterior view of a tip of the invention assembled together with an applicator.



FIG. 5 depicts a transparent view of a tip of the invention assembled in combination with an applicator as in FIG. 4.





DETAILED DESCRIPTION OF THE INVENTION

Neurosurgical procedures, such as craniotomy and spinal surgery, frequently involve penetration of the dura mater. Many of these procedures are characterized by sites with limited or difficult access owing to their anatomy and/or the use of minimally invasive techniques and equipment. For example, certain infratentorial, skull base, and spinal surgical procedures present limited or difficult access.


Applicant currently markets, as Adherus AutoSpray Dural Sealant, a sterile, single-use, electromechanical, battery-operated device with internal system components that (i) provide air flow to aid in the delivery of a synthetic, absorbable, two-component hydrogel sealant system, and (ii) allow delivery to be interrupted without clogging. The device is supplied as a pre-assembled applicator and two separate glass vials containing the crosslinking components which, when prepared and mixed, create hyperbranched globular structures through the crosslinking of a polyfunctional nucleophile with a bifunctional electrophile. The product is simple to prepare and, once applied to the dural surface, quickly cures to form a watertight seal. Adherus AutoSpray Dural Sealant is a single-use device supplied terminally sterilized by radiation. See U.S. Patent Application Publication No. 2013/0338631, the entire content of which is incorporated herein by reference.


The Adherus AutoSpray Dural Sealant has a relatively short or “stub-nosed” or “snub-nosed” tip which creates a locally directed spray comprised of the combined components of the hydrogel sealant. See FIG. 1. The standard length tip is well suited for use in procedures with relatively wide surgical access.


The instant invention provides an extended and flexible tip suitable for use in delivering a two-component liquid composition as a locally directed spray. The extended, flexible tip is specifically useful in conjunction with delivery of a two-component hydrogel sealant, such as is described in U.S. Pat. No. 8,410,189 and U.S. Patent Application Publication No. 2007/0196454 (both of which are incorporated by reference). Additionally, the extended, flexible tip is specifically useful as a modification of the Adherus AutoSpray Dural Sealant described above, whereby the extended, flexible tip of the invention is substituted for the snub-nosed, standard length tip of the applicator device/system.


Advantages of the extended, flexible tip of the invention include its ability to access confined, hard-to-reach surgical sites that otherwise allow only limited access, such as infratentorial, skull base (e.g., transsphenoidal), and spinal sites; and the ability to provide improved visualization for the operator during use. For example, the extended length of the tip permits improved accessibility, and the flexibility of the tip permits positioning of the applicator handset out of the line of sight of the applicator tip.


In one embodiment, the extended, flexible tip of the invention is incorporated into a pre-assembled, ready-for-use sterile applicator that reduces preparation time and allows the controlled application of a hydrogel formulation within confined, hard-to-reach areas, e.g., of the cranium and spine, without clogging. For example, the extended, flexible tip may be incorporated into a sterile, single-use, electromechanical, battery operated, device with internal system components that provide air flow to aid in the delivery of a synthetic, absorbable, two-component hydrogel sealant system and allow delivery to be interrupted without clogging. In one embodiment the device is supplied as a pre-assembled applicator and two separate glass vials containing the crosslinking components which, when prepared and mixed, create hyperbranched globular structures through the crosslinking of a polyfunctional nucleophile with a bifunctional electrophile.


An aspect of the invention is a tip assembly, comprising

    • a proximal end, comprising a Y fitting, the Y fitting comprising
      • a first proximal end;
      • a second proximal end;
      • a distal end;
      • a first fluid channel extending from the first proximal end to the distal end; and
      • a second fluid channel extending from the second proximal end to the distal end;
    • a distal end;
    • a mixing nozzle, comprising
      • a proximal end, comprising a fluid inlet;
      • a distal end, comprising a fluid outlet, wherein the distal end of the mixing nozzle corresponds to the distal end of the tip assembly; and
      • a mixing chamber disposed between and in fluid communication with the fluid inlet and the fluid outlet;
    • a tube extending from the distal end of the Y fitting to the proximal end of the mixing nozzle;
    • a first cannula, disposed within and extending along substantially the entire length of the tube, in fluid communication with the first fluid channel of the Y fitting and the fluid inlet of the mixing nozzle; and
    • a second cannula, disposed within and extending along substantially the entire length of the tube, in fluid communication with the second fluid channel of the Y fitting and the fluid inlet of the mixing nozzle;
    • wherein the tube, the first cannula, and the second cannula are flexible.


In an embodiment, the first cannula further extends along substantially the entire length of the first fluid channel of the Y fitting; and the second cannula further extends along substantially the entire length of the second fluid channel of the Y fitting. In such an embodiment the Y fitting can be formed, for example, by injection molding around at least a portion of the proximal ends of the cannulae.


In certain embodiments, the first cannula and the second cannula are made of annealed stainless steel tubing. The annealed stainless steel tubing provides a desirable combination of both stiffness and flexibility, e.g., bendability.


In certain embodiments, the cannulae are identical in length and inside diameter.


In certain embodiments, the cannulae have an inside diameter of about 0.03 inches (0.76 millimeters (mm)) to about 0.05 inches (1.27 mm).


In certain embodiments, the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 12 centimeters (cm) to about 20 cm.


In certain embodiments, the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 12 cm to about 15 cm.


In certain embodiments, the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 12 cm.


In certain embodiments, the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 1 cm to less than about 12 cm.


In certain embodiments, the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 1 cm to about 10 cm.


In certain embodiments, the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 1 cm to about 8 cm.


In certain embodiments, the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 1 cm to about 6 cm.


In certain embodiments, the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 1 cm to about 4 cm.


In certain embodiments, the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 2 cm to less than about 12 cm.


In certain embodiments, the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 2 cm to about 10 cm.


In certain embodiments, the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 2 cm to about 8 cm.


In certain embodiments, the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 2 cm to about 6 cm.


In certain embodiments, the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 2 cm to about 4 cm.


In certain embodiments, the tip assembly further comprises a tubing adapter which, as a sleeve, accepts the distal end of the Y fitting and the proximal end of the tube. See FIG. 2 and FIG. 3.


In certain embodiments, the length of the assembly from the distal end of the tubing adapter to the distal end of the mixing nozzle is about 12 centimeters (cm) to about 20 cm.


In certain embodiments, the length of the assembly from the distal end of the tubing adapter to the distal end of the mixing nozzle is about 12 cm to about 15 cm.


In certain embodiments, the length of the assembly from the distal end of the tubing adapter to the distal end of the mixing nozzle is about 12 cm.


In certain embodiments, the length of the assembly from the distal end of the tubing adapter to the distal end of the mixing nozzle is about 1 cm to less than about 12 cm.


In certain embodiments, the length of the assembly from the distal end of the tubing adapter to the distal end of the mixing nozzle is about 1 cm to about 10 cm.


In certain embodiments, the length of the assembly from the distal end of the tubing adapter to the distal end of the mixing nozzle is about 1 cm to about 8 cm.


In certain embodiments, the length of the assembly from the distal end of the tubing adapter to the distal end of the mixing nozzle is about 1 cm to about 6 cm.


In certain embodiments, the length of the assembly from the distal end of the tubing adapter to the distal end of the mixing nozzle is about 1 cm to about 4 cm.


In certain embodiments, the length of the assembly from the distal end of the tubing adapter to the distal end of the mixing nozzle is about 2 cm to less than about 12 cm.


In certain embodiments, the length of the assembly from the distal end of the tubing adapter to the distal end of the mixing nozzle is about 2 cm to about 10 cm.


In certain embodiments, the length of the assembly from the distal end of the tubing adapter to the distal end of the mixing nozzle is about 2 cm to about 8 cm.


In certain embodiments, the length of the assembly from the distal end of the tubing adapter to the distal end of the mixing nozzle is about 2 cm to about 6 cm.


In certain embodiments, the length of the assembly from the distal end of the tubing adapter to the distal end of the mixing nozzle is about 2 cm to about 4 cm.


In certain embodiments, the tip assembly further comprises a third fluid channel, wherein the third fluid channel is defined by and extends from a proximal inlet of the Y fitting, along and within the tube, to a distal outlet in fluid communication with the mixing chamber of the mixing nozzle.


In certain embodiments, the proximal inlet of the Y fitting comprises a fitting suitable for receiving a gas from a gas reservoir or source of gas. In one embodiment, the gas is air. The gas reservoir or source of gas may be a gas-pump that is a built-in component of an applicator.


In certain embodiments, the tube comprises polymeric material that may be sterilized by radiation.


In certain embodiments, the tube is made of polytetrafluoroethylene (Teflon®, DuPont).


In certain embodiments, the tube is made from phthalate-free medical grade polyvinyl chloride (PVC).


In certain embodiments, the tube has a maximum outside diameter of about 5.5 millimeters (mm), and the mixing nozzle has a maximum outside diameter of about 5.5 mm.


In certain embodiments, the tube has a maximum outside diameter of about 5.2 mm, and the mixing nozzle has a maximum outside diameter of about 5.2 mm.


In certain embodiments, the tube and its contents together can be bent at least 30° over a 2.25-inch span upon application of force no less than about 1 pound and no more than about 24 pounds. Advantageously, the tube and its contents (e.g., the two cannulae) can be readily bent by hand, with or without the aid of any tool, thereby permitting operating room personnel (e.g., surgeon) the ability to conform, and even re-conform, the tube to a shape of choice.


An aspect of the invention is a multi-component delivery system, comprising the tip assembly described herein. In a preferred embodiment, the tip assembly of the invention is substituted for the corresponding tip assembly in the multi-component delivery system disclosed in U.S. Patent Application Publication No. 2013/0338631, the entire content of which is incorporated herein by reference. See FIG. 4 and FIG. 5. In one embodiment, the Y fitting is enclosed within the handset of the system, while substantially the remainder of the tip assembly—including the tube and its contents, at least a distal portion of the tubing adapter (if present), and the mixing nozzle—projects and extends distally from the housing of the handset. See FIG. 4 and FIG. 5.


An aspect of the invention is a method of using the tip assembly of the invention. The method comprises the steps of:

    • bringing a source of a first component of a two-component system into fluid communication with the first fluid channel;
    • bringing a source of a second component of a two-component system into fluid communication with the second fluid channel;
    • causing the first component to traverse the first cannula;
    • causing the second component to traverse the second cannula;
    • causing the first component to mix with the second component within the mixing chamber, thereby forming a mixture; and
    • expelling the mixture through the fluid outlet of the mixing nozzle, thereby forming a spray of the mixture.


In an embodiment, the first component and the second component are components of an adhesive. For example, the first component and the second component can be a urethane and a fibrin, respectively. As another example, the first component and the second component can be a polyalkyleneimine and an activated PEG, respectively. As yet another example, the first component and the second component can be PEI and an activated PEG, respectively.


In an embodiment, the first component and the second component are components of a sealant. For example, the first component and the second component can be a urethane and a fibrin, respectively. As another example, the first component and the second component can be a polyalkyleneimine and an activated PEG, respectively. As yet another example, the first component and the second component can be PEI and an activated PEG, respectively.


In an embodiment, at least one of the first component and the second component can comprise a drug or other biologically active component.


In an embodiment, at least one of the first component and the second component is a drug or other biologically active component.


In an embodiment, the method further comprises bending the tube and its contents. For example, the tube and its contents may be bent an amount sufficient to permit improved access to a surgical site having limited or difficult access. In certain embodiments, the tube and its contents may be bent an amount sufficient to permit improved line of sight for the operator (e.g., surgeon).


In certain embodiments, the tube and its contents can be bent in one or more locations. In certain embodiments, the tube and its contents can be bent in one location. In certain embodiments, the tube and its contents can be bent in two locations. In certain embodiments, the tube and its contents can be bent in three locations. When there is more than one bend, each bend can be made independent of any other, in terms of acuity, direction, and plane.


In respect of each bend, in certain embodiments, the tube and its contents may be bent by up to about 10°. In respect of each bend, in certain embodiments, the tube and its contents may be bent by up to about 20°. In respect of each bend, in certain embodiments, the tube and its contents may be bent by up to about 30°. In respect of each bend, in certain embodiments, the tube and its contents may be bent by up to about 40°. In respect of each bend, in certain embodiments, the tube and its contents may be bent by up to about 45°.


An aspect of the invention is a method of using the tip assembly of the invention. The method comprises the steps of:

    • bringing a source of a first component of a two-component hydrogel into fluid communication with the first fluid channel;
    • bringing a source of a second component of a two-component hydrogel into fluid communication with the second fluid channel;
    • causing the first component to traverse the first cannula;
    • causing the second component to traverse the second cannula;
    • causing the first component to mix with the second component within the mixing chamber, thereby forming a pre-hydrogel mixture; and
    • expelling the pre-hydrogel mixture through the fluid outlet of the mixing nozzle, thereby forming a spray of the pre-hydrogel mixture.


In an embodiment, the method further comprises bending the tube and its contents. For example, the tube and its contents may be bent an amount sufficient to permit improved access to a surgical site having limited or difficult access. In certain embodiments, the tube and its contents may be bent an amount sufficient to permit improved line of sight for the operator (e.g., surgeon).


In certain embodiments, the tube and its contents can be bent in one or more locations. In certain embodiments, the tube and its contents can be bent in one location. In certain embodiments, the tube and its contents can be bent in two locations. In certain embodiments, the tube and its contents can be bent in three locations. When there is more than one bend, each bend can be made independent of any other, in terms of acuity, direction, and plane.


In respect of each bend, in certain embodiments, the tube and its contents may be bent by up to about 10°. In respect of each bend, in certain embodiments, the tube and its contents may be bent by up to about 20°. In respect of each bend, in certain embodiments, the tube and its contents may be bent by up to about 30°. In respect of each bend, in certain embodiments, the tube and its contents may be bent by up to about 40°. In respect of each bend, in certain embodiments, the tube and its contents may be bent by up to about 45°.


In an embodiment, the spray is applied to dura mater of a subject.


In an embodiment, the dura mater is cranial dura mater.


In an embodiment, the dura mater is spinal dura mater.


In certain embodiments, the method is part of a neurosurgical procedure.


In an embodiment, the neurosurgical procedure is infratentorial craniotomy.


In an embodiment, the neurosurgical procedure is skull base craniotomy.


In an embodiment, the neurosurgical procedure is transsphenoidal craniotomy.


In an embodiment, the neurosurgical procedure is surgery on the spine.


In certain embodiments, the spray is applied to a mesh implant, e.g., a hernia repair mesh, in situ.


In certain embodiments, the spray is applied to a tissue of interest to prevent or reduce the development of adhesion formation between the tissue of interest and another tissue.


In certain embodiments, the method is part of a hernia repair procedure, e.g., a femoral, inguinal, or abdominal hernia repair.


In certain embodiments, the method is part of an abdominal surgical procedure, including, without limitation, exploratory laparotomy, stomach or bowel resection or repair, bowel reanastomosis, gastroplasty, appendectomy, cholecystectomy, splenectomy, nephrectomy, tubal ligation or resection, tumor resection, and repair of abdominal aortic aneurysm.


In certain embodiments, the method is part of a thoracic surgical procedure.


The invention further contemplates methods of using the tip assembly of the invention with only a single component. For example, also contemplated is a method comprising the steps of:


bringing a source of a component into fluid communication with the first fluid channel;


causing the component to traverse the first cannula; and


expelling the component through the fluid outlet of the mixing nozzle, thereby forming a spray of the component.


The invention now being generally described, it will be more readily understood by reference to the following examples, which are included merely for purposes of illustration of certain aspects and embodiments of the present invention, and are not intended to limit the invention.


EXAMPLES
Example 1

All tubing (cannulae) was 1/16″ outside diameter, annealed stainless steel. Teflon tubing was used as the exterior polymer tubing sheath (tube).


Results


a) Samples with 0.030″ inside diameter (ID) tubing had very little dripping during start-and-stop operations. Gravimetric swelling=22.4±6.22 (mean±std. dev) percent vs. 18% on control units of same formulation but current stub-nose AutoSpray.


b) Samples with 0.020″ inside diameter exhibited much worse spray behavior.


Lots of dripping of PEG solution during stop operation (with air pump on).


Gravimetric swelling=24.8±3.1%


Gravimetric swelling is a measure of the completeness of mixing and polymerization. If not well mixed, or if the two liquids are not proportioned correctly, the swelling will be higher.


CONCLUSION: Unexpectedly, the larger inside diameter was better. (Prior to experiment I would have predicted a smaller inside diameter would be better, i.e., have less of a chance to allow PEG or PEI solution to leak out during stop operation.


Example 2

Tubing (cannulae) with 0.030″, 0.040″ and 0.046″ ID.






    • a) 0.030″ ID samples—Same performance as Example 1. Small amount of drips during stop operation. Gravimetric swelling=25.0±4.14%

    • b) 0.040″ ID samples—Similar dripping performance as 0.030″ samples. Gravimetric swelling=24.3±4.9%

    • c) 0.046″ ID samples—Noticeably improved drip performance over 0.030″ and 0.040″ samples. Gravimetric swelling=14.3±3.05%





INCORPORATION BY REFERENCE

All of the U.S. patents and U.S. patent application publications cited herein are hereby incorporated by reference.


EQUIVALENTS

Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the following claims.

Claims
  • 1. A tip assembly, comprising a proximal end, comprising a Y fitting, the Y fitting comprisinga first proximal end;a second proximal end, the first and second proximal ends connected to an applicator;a distal end;a first fluid channel extending from the first proximal end to the distal end, the first fluid channel including a first section and a second section perpendicular to the first section; anda second fluid channel extending from the second proximal end to the distal end, the second fluid channel including a third section and a fourth section perpendicular to the third section;a distal end;a mixing nozzle, comprisinga proximal end, comprising a fluid inlet;a distal end, comprising a fluid outlet, wherein the distal end of the mixing nozzle corresponds to the distal end of the tip assembly; anda mixing chamber disposed between and in fluid communication with the fluid inlet and the fluid outlet;a tube extending from the distal end of the Y fitting to the proximal end of the mixing nozzle, the tube defining a tube cross section;a first cannula, disposed within and extending along substantially the entire length of the tube, in fluid communication with the first fluid channel of the Y fitting and the fluid inlet of the mixing nozzle, the first cannula being perpendicular to the second section of the first channel, the first cannula defining a first cross section;a second cannula, disposed within and extending along substantially the entire length of the tube, in fluid communication with the second fluid channel of the Y fitting and the fluid inlet of the mixing nozzle, the second cannula being perpendicular to the fourth section of the second channel, the second cannula defining a second cross section, anda third fluid channel extending from a proximal inlet of the Y fitting to a distal outlet in fluid communication with the mixing chamber of the mixing nozzle, the third fluid channel having a third cross section, wherein the third cross section is equal to the tube cross section minus the first and second cross sections, the third fluid channel being in fluid communication with a built-in gas pump of the applicator,wherein the tube, the first cannula, and the second cannula are flexible.
  • 2. The tip assembly of claim 1, wherein the first cannula further extends along substantially the entire length of the first fluid channel of the Y fitting; and the second cannula further extends along substantially the entire length of the second fluid channel of the Y fitting.
  • 3. The tip assembly of claim 1, wherein the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 12 cm to about 20 cm.
  • 4. The tip assembly of claim 3, wherein the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 12 cm to about 15 cm.
  • 5. The tip assembly of claim 3, wherein the length of the assembly from the distal end of the Y fitting to the distal end of the mixing nozzle is about 12 cm.
  • 6. The tip assembly of claim 1, wherein the tube comprises polymeric material that may be sterilized by radiation.
  • 7. The tip assembly of claim 6, wherein the tube is made of polytetrafluoroethylene.
  • 8. The tip assembly of claim 6, wherein the tube is made from phthalate-free medical grade polyvinyl chloride (PVC).
  • 9. The tip assembly of claim 1, wherein the tube has a maximum outside diameter of about 5.5 millimeters (mm), and the mixing nozzle has a maximum outside diameter of about 5.5 mm.
  • 10. The tip assembly of claim 9, wherein the tube has a maximum outside diameter of about 5.2 mm, and the mixing nozzle has a maximum outside diameter of about 5.2 mm.
  • 11. A multi-component delivery system, comprising the tip assembly of claim 1.
  • 12. The tip assembly of claim 1, wherein the first cannula and the second cannula have an inside diameter of about 0.03 inches.
  • 13. The tip assembly of claim 1, wherein the first cannula and the second cannula have an inside diameter of about 0.046 inches.
  • 14. A method of using the tip assembly of claim 1, comprising bringing a source of a first component of a two-component hydrogel into fluid communication with the first fluid channel;bringing a source of a second component of a two-component hydrogel into fluid communication with the second fluid channel;causing the first component to traverse the first cannula;causing the second component to traverse the second cannula;causing the first component to mix with the second component within the mixing chamber, thereby forming a pre-hydrogel mixture; andexpelling the pre-hydrogel mixture through the fluid outlet of the mixing nozzle, thereby forming a spray of the pre-hydrogel mixture.
  • 15. The method of claim 14, further comprising bending the tube and its contents.
  • 16. The method of claim 14, wherein said spray is applied to dura mater of a subject.
  • 17. The method of claim 16, wherein said dura mater is cranial dura mater.
  • 18. The method of claim 16, wherein said dura mater is spinal dura mater.
  • 19. The method of claim 14, wherein the method is part of a neurosurgical procedure.
  • 20. The method of claim 19, wherein the neurosurgical procedure is infratentorial craniotomy.
  • 21. The method of claim 19, wherein the neurosurgical procedure is skull base craniotomy.
  • 22. The method of claim 19, wherein the neurosurgical procedure is transsphenoidal craniotomy.
  • 23. The method of claim 19, wherein the neurosurgical procedure is surgery on the spine.
RELATED APPLICATION

This application claims benefit of U.S. Provisional Patent Application No. 61/975,328, filed Apr. 4, 2014.

US Referenced Citations (229)
Number Name Date Kind
3092964 Martin et al. Jun 1963 A
3112074 Green Nov 1963 A
3214102 Meyer Oct 1965 A
3495544 Enssle Feb 1970 A
3828980 Creighton et al. Aug 1974 A
4040420 Speer Aug 1977 A
4071196 Burke et al. Jan 1978 A
4359049 Redl et al. Nov 1982 A
4538920 Drake Sep 1985 A
4631055 Redl et al. Dec 1986 A
4706888 Dobbs Nov 1987 A
4735616 Eibl et al. Apr 1988 A
4753536 Spehar et al. Jun 1988 A
4767026 Keller et al. Aug 1988 A
4767416 Wolf et al. Aug 1988 A
4826048 Skorka et al. May 1989 A
4842581 Davis Jun 1989 A
4846405 Zimmermann Jul 1989 A
4874368 Miller et al. Oct 1989 A
4902281 Avoy Feb 1990 A
4978336 Capozzi et al. Dec 1990 A
4979942 Wolf et al. Dec 1990 A
5033650 Colin et al. Jul 1991 A
5049135 Davis Sep 1991 A
5080649 Vetter Jan 1992 A
5104375 Wolf et al. Apr 1992 A
5116315 Capozzi et al. May 1992 A
5249709 Duckworth et al. Oct 1993 A
5249862 Herold et al. Oct 1993 A
5290228 Uemura et al. Mar 1994 A
5328462 Fischer Jul 1994 A
5333760 Simmen Aug 1994 A
5334163 Sinnett Aug 1994 A
5341993 Haber et al. Aug 1994 A
5360410 Blacks Nov 1994 A
5368563 Lonneman et al. Nov 1994 A
5413253 Simmen May 1995 A
5445614 Haber et al. Aug 1995 A
5474540 Miller et al. Dec 1995 A
5582596 Fukunaga et al. Dec 1996 A
5605255 Reidel et al. Feb 1997 A
5605541 Holm Feb 1997 A
5643206 Fischer Jul 1997 A
5645855 Lorenz Jul 1997 A
5656035 Avoy Aug 1997 A
5678764 Kukesh Oct 1997 A
5740965 Miyagi et al. Apr 1998 A
5759171 Coelho et al. Jun 1998 A
5810885 Zinger Sep 1998 A
5819988 Sawhney et al. Oct 1998 A
5876384 Dragan Mar 1999 A
5887755 Hood, III Mar 1999 A
5890655 Collias et al. Apr 1999 A
5941462 Sandor Aug 1999 A
5980866 Uchida et al. Nov 1999 A
6004547 Rowe et al. Dec 1999 A
6047861 Vidal et al. Apr 2000 A
6059749 Marx May 2000 A
6065645 Sawhney et al. May 2000 A
6113571 Zinger et al. Sep 2000 A
6132396 Antanavich et al. Oct 2000 A
6143805 Hickey et al. Nov 2000 A
6161730 Heusser et al. Dec 2000 A
6206905 Holm et al. Mar 2001 B1
6228051 Trumbull May 2001 B1
6234356 Garbasch et al. May 2001 B1
6248800 Greff et al. Jun 2001 B1
6251370 Uchida et al. Jun 2001 B1
6310166 Hickey et al. Oct 2001 B1
6322852 Leung Nov 2001 B1
6328229 Duronio et al. Dec 2001 B1
6379373 Sawhney et al. Apr 2002 B1
6398761 Bills et al. Jun 2002 B1
6422865 Fischer Jul 2002 B1
6454786 Holm et al. Sep 2002 B1
6461325 Delmotte et al. Oct 2002 B1
6461361 Epstein Oct 2002 B1
6468520 Rowe et al. Oct 2002 B1
6527749 Roby et al. Mar 2003 B1
6540716 Holm Apr 2003 B1
6565539 Zinger et al. May 2003 B1
6579916 Askill et al. Jun 2003 B1
6585696 Petersen et al. Jul 2003 B2
6609666 Blake Aug 2003 B1
6613020 Holm et al. Sep 2003 B1
6648852 Wirt et al. Nov 2003 B2
6673093 Sawhney Jan 2004 B1
6698622 Sawhney et al. Mar 2004 B2
6752292 Van Herpen Jun 2004 B2
6769574 Keller Aug 2004 B1
6773414 Ljungquist Aug 2004 B2
6783514 Tovey et al. Aug 2004 B2
6820766 Keller et al. Nov 2004 B2
6835186 Pennington et al. Dec 2004 B1
6852099 Redl et al. Feb 2005 B2
6874657 Metzner et al. Apr 2005 B2
6884232 Hagmann et al. Apr 2005 B1
6921381 Spero et al. Jul 2005 B2
6949114 Milo et al. Sep 2005 B2
6960340 Rowe et al. Nov 2005 B2
6994686 Cruise et al. Feb 2006 B2
7009034 Pathak et al. Mar 2006 B2
7037289 Dodge et al. May 2006 B2
7037490 Rowe et al. May 2006 B2
7077339 Leach Jul 2006 B2
7124574 Horn et al. Oct 2006 B2
7124914 Foster et al. Oct 2006 B2
7128278 Archambeau et al. Oct 2006 B2
7131597 Scattergood Nov 2006 B2
7140558 McCracken et al. Nov 2006 B2
7140560 Stotts et al. Nov 2006 B2
7140797 Hunter et al. Nov 2006 B2
7152396 Cheng Dec 2006 B2
7152813 Chen Dec 2006 B2
7156835 Epstein Jan 2007 B2
7159796 Yquel Jan 2007 B2
7164133 Hjertman et al. Jan 2007 B2
7172733 Gauthier et al. Feb 2007 B2
7173733 Nino et al. Feb 2007 B2
7178742 Mellentine et al. Feb 2007 B2
7178743 Clarke, III et al. Feb 2007 B2
7178744 Tapphorn et al. Feb 2007 B2
7182279 Wang Feb 2007 B2
7185829 Sundholm Mar 2007 B2
7191917 Brinz et al. Mar 2007 B2
7191959 Kutay et al. Mar 2007 B2
7195135 Garcia et al. Mar 2007 B1
7195180 Lee Mar 2007 B2
7201336 Blette et al. Apr 2007 B2
7207969 Epstein et al. Apr 2007 B2
7217254 Kirwan et al. May 2007 B2
7222752 Ponton May 2007 B2
7223426 Cheng et al. May 2007 B2
7225999 Foianini et al. Jun 2007 B2
7232080 Kutay et al. Jun 2007 B2
7232082 Muhlhausen et al. Jun 2007 B2
7237693 Brennan et al. Jul 2007 B2
7237726 Yu Jul 2007 B2
7244248 Azzolini Jul 2007 B2
7246758 Wang Jul 2007 B2
7252243 Bjorn et al. Aug 2007 B2
7252247 Holm et al. Aug 2007 B2
7264179 Robbins Sep 2007 B2
7267288 Wheeler, Jr. et al. Sep 2007 B2
7270654 Griego et al. Sep 2007 B2
7275699 Schmidt Oct 2007 B2
7278985 Ågerup Oct 2007 B2
7332566 Pathak et al. Feb 2008 B2
7347850 Sawhney Mar 2008 B2
7351249 Hnojewyj et al. Apr 2008 B2
7427607 Suzuki Sep 2008 B2
7537174 Redl et al. May 2009 B2
7592418 Pathak et al. Sep 2009 B2
7611494 Campbell et al. Nov 2009 B2
7682336 Hoogenakker et al. Mar 2010 B2
7731678 Tennican et al. Jun 2010 B2
7811291 Liu et al. Oct 2010 B2
7833216 Voegele et al. Nov 2010 B2
7846125 Yatabe et al. Dec 2010 B2
7896849 Delay Mar 2011 B2
8003705 Sawhney et al. Aug 2011 B2
8033483 Fortier et al. Oct 2011 B2
8057426 Nayak et al. Nov 2011 B2
8057427 Griffiths et al. Nov 2011 B2
8066678 Vaillancourt et al. Nov 2011 B2
8152777 Campbell et al. Apr 2012 B2
8210453 Hull et al. Jul 2012 B2
8262608 Clark et al. Sep 2012 B2
8287566 Leopold et al. Oct 2012 B2
8292846 Sargeant et al. Oct 2012 B2
8303531 Sharratt Nov 2012 B2
8323262 D'Alessio et al. Dec 2012 B2
8343183 D'Alessio et al. Jan 2013 B2
8357147 Burkinshaw et al. Jan 2013 B2
8376989 Rissman et al. Feb 2013 B2
8377507 Wawrzyniak et al. Feb 2013 B2
8387899 Fortier et al. Mar 2013 B2
8408480 Hull et al. Apr 2013 B2
8469289 Redl et al. Jun 2013 B2
8534575 Brem Sep 2013 B2
8545457 Hayakawa Oct 2013 B2
8616468 Hull et al. Dec 2013 B2
8640921 Meron et al. Feb 2014 B2
8641662 Barker, Jr. et al. Feb 2014 B2
8672237 Roush et al. Mar 2014 B2
8684282 Steffen Apr 2014 B2
8827980 Ji Sep 2014 B2
8876021 Fortier et al. Nov 2014 B2
8973596 Hull Mar 2015 B2
8974436 Sherman et al. Mar 2015 B2
9101946 Hull et al. Aug 2015 B2
9125633 Roush et al. Sep 2015 B2
9179898 Redl et al. Nov 2015 B2
9205207 Ji Dec 2015 B2
9211554 Brunk et al. Dec 2015 B2
9211555 Meron et al. Dec 2015 B2
9370630 Greter Jun 2016 B2
9381005 Masson et al. Jul 2016 B2
9433959 Krauss et al. Sep 2016 B2
9445795 Ohri et al. Sep 2016 B2
9486190 Sherman et al. Nov 2016 B2
9517478 Hull et al. Dec 2016 B2
9572555 Lai et al. Feb 2017 B1
9579449 Sharma et al. Feb 2017 B2
9586005 Steffen Mar 2017 B2
9622731 Peindl et al. Apr 2017 B2
9629966 Ji Apr 2017 B2
9681860 Steffen Jun 2017 B2
9700290 Hull et al. Jul 2017 B2
9782549 Riebman et al. Oct 2017 B2
20020022588 Wilkie et al. Feb 2002 A1
20020176732 Quintero et al. Nov 2002 A1
20040050963 Ray Mar 2004 A1
20060045900 Richard et al. Mar 2006 A1
20070083086 LeVahn Apr 2007 A1
20070196454 Stockman Aug 2007 A1
20070203451 Murakami Aug 2007 A1
20080195040 Clark et al. Aug 2008 A1
20090124986 Hayakawa May 2009 A1
20090199848 Sharratt Aug 2009 A1
20100114158 Hattan et al. May 2010 A1
20100280312 D'Alessio Nov 2010 A1
20110015736 Sharim Jan 2011 A1
20130110161 Sherman et al. May 2013 A1
20130146679 Fortier et al. Jun 2013 A1
20130338631 Butlin et al. Dec 2013 A1
20140012184 Lynch Jan 2014 A1
20140014213 Hull Jan 2014 A1
20140088645 Sengun Mar 2014 A1
Foreign Referenced Citations (29)
Number Date Country
2150253 Apr 1995 CA
29516077 Feb 1997 DE
69127614 Apr 1998 DE
69827132 Mar 2006 DE
60108786 Apr 2006 DE
0170526 Feb 1986 EP
0689874 Jan 1996 EP
0814866 Jan 1998 EP
1188455 Mar 2002 EP
1955660 Aug 2008 EP
2111918 Oct 2009 EP
2 311 376 Apr 2011 EP
2869533 Nov 2005 FR
1469009 Mar 1977 GB
9629113 Sep 1996 WO
9902207 Jan 1999 WO
2002005898 Jan 2002 WO
WO-02055138 Jul 2002 WO
02076534 Oct 2002 WO
03047530 Jun 2003 WO
2005009225 Feb 2005 WO
2005048984 Jun 2005 WO
2005103184 Nov 2005 WO
2006034128 Mar 2006 WO
2006060055 Jun 2006 WO
2007127903 Nov 2007 WO
2007131371 Nov 2007 WO
WO-2009097271 Aug 2009 WO
2014008445 Jan 2014 WO
Non-Patent Literature Citations (5)
Entry
International Preliminary Report on Patentability for PCT/US2015/023974 dated Oct. 13, 2016.
International Search Report and Written Opinion from corresponding PCT application PCT/US2015/023974 dated Jul. 26, 2015.
Extended European Search Report issued by the European Patent Office in corresponding Application No. 15772951.8, dated Nov. 6, 2017.
International Search report for PCT/US2008/052025 dated Sep. 1, 2009.
Partial International Search Report for PCT/US2008/052025, dated Feb. 6, 2009.
Related Publications (1)
Number Date Country
20150282794 A1 Oct 2015 US
Provisional Applications (1)
Number Date Country
61975328 Apr 2014 US